C8A Antikörper (AA 21-300)

Produktnummer ABIN5013379

Dieses Anti-C8A-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von C8A in WB. Geeignet für Ratte.

Kurzübersicht für C8A Antikörper (AA 21-300) (ABIN5013379)

Target: C8A (Complement Component 8, alpha Polypeptide (C8A))

Reaktivität: Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser C8A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-C8A Antikörper

Bindungsspezifität: AA 21-300

Verwendungszweck: Polyclonal Antibody to Complement Component 8a (C8a)

Spezifität: The antibody is a rabbit polyclonal antibody raised against C8a. It has been selected for its ability to recognize C8a in immunohistochemical staining and western blotting.

Aufreinigung: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogen: RPD784Ra01Recombinant Complement Component 8a (C8a)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Western blotting: 0.01-2 μg/mL,Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Konservierungsmittel: ProClin

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Details zu C8A

Target: C8A (Complement Component 8, alpha Polypeptide (C8A))

Andere Bezeichnung: Complement Component 8a

Hintergrund: Complement Component 8,Alpha Polypeptide, Complement Component 8 Deficiency,Type I

Pathways: Komplementsystem